With regard to this issue, Tomizawa et al (2002) pointed out that RASSF1A methylation was correlated with poor prognosis in NSCLC patients at stage I. On the other hand, Endoh et al (2003) reported that there was no correlation. Here, RASSF1 is linked to non-small cell lung carcinoma.